Treskova, Martina http://orcid.org/0000-0002-3641-7225
Scholz, Stefan
Kuhlmann, Alexander
Mahlich, Jörg
Stoll, Matthias
Funding for this research was provided by:
Janssen-Cilag grant
Article History
Received: 18 September 2019
Accepted: 9 March 2021
First Online: 30 March 2021
Declarations
:
: The CORSAR survey was approved by the national regulatory authorities and local ethics committees of all participating centres. All patients were given thorough information on the survey. Before the participation in the interviews, the patients provided written consent. No incentive was offered to the probands for their participation in the survey.
: Not applicable.
: By the fact that the patients had been receiving cART before the enrollment into the study, the selection of cART regimen in the sample was not influenced by the authors.MS has received honoraria as an advisor and lecturer in studies funded by Abbvie, Boehringer-Ingelheim, Bristol-Myers-Squibb, Gilead, Glaxo-Smith-Kline, Hexal, Janssen-Cilag, Merck Sharp & Dohme, and ViiV Healthcare. He was a board member at Abbvie, Gilead Sciences, Hexal, Janssen-Cilag, and ViiV Healthcare.JM is an employee and stockholder at Janssen-Cilag GmbH, Johnson & Johnson GmbH.MT and AK declared no conflict of interest.